An investor, who purchased shares of Akero Therapeutics, Inc. (NASDAQ: AKRO), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Fe… Read More
Dental Hygiene Devices Market Outlook
The global dental hygiene devices market size was valued at USD 6.5 billion in 2023, driven by rising focus on optimal dental health across the globe. T… Read More
In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. While it isn’t known whether 2024 might beat that record, it will surely be… Read More
Introduction
In a landscape where many contract research organizations (CROs) are available, Vial is breaking through with its promise to deliver on its vision to empower scientists to cu… Read More
--News Direct--Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the m… Read More
--News Direct--Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire tells Proactive's Stephen Gunnion the company has successfully raised £715,000 through a mix of placeme… Read More
If there’s one thing that can quickly send a healthcare stock soaring, it’s the approval of a key drug. Not only can that give investors confidence in a business’s abil… Read More
After a long list of failures, a much-awaited treatment for noncirrhotic non-alcoholic steatohepatitis (NASH), recently renamed metabolic dysfunction-associated steatohepatitis (MASH), has f… Read More
Wilmington, Delaware, United States, 2024-Mar-01 — /EPR Network/ — Nonalcoholic steatohepatitis (NASH) represents a significant and growing public health concern worldwide, chara… Read More
M&A in the pharmaceutical industry is looking at an exceptional surge in activity in 2024 and the upcoming years. Mergers and acquisitions are the most viable strategies for companies to… Read More
The global market size for Non-Alcoholic Steatohepatitis (NASH) was USD 2.42 billion in 2022 and is anticipated to reach USD 13.45 billion by 2032, demonstrating a compound annual growth rat… Read More
Stocks have rallied this week, with the major averages headed for their seventh straight week in the green, and investors are betting this momentum will continue moving forward. The S &am… Read More
Eli Lily and Novo Nordisk, two pharmaceutical giants in the diabetes and obesity treatment market, have recently revealed their ambitious plans to expand their offerings to include comprehen… Read More
A detailed analysis of the Global Non-Alcoholic Steatohepatitis (NASH) Market 2023 is provided, including global, regional, and country-level market Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Alcoholic Steatohepatitis pipeline constitutes 100+ key companies continuously working towards deve… Read More
Small cap stocks are an attractive and often lucrative opportunity for investors due to their potential to outperform their larger counterparts. These smaller companies possess several advan… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Alcoholic Fatty Liver Disease pipeline constitutes 110+ key companies continuously working towards… Read More
Introduction:
Market Insights
The TechSci Research report titled “Global Digital Pathology Market – Industry Size, Share, Trends, Competition Forecast & Opportunities… Read More
When it comes to penny stocks, it's important to exercise caution and conduct thorough research. While there are no guarantees, some penny stocks have shown potential for growth. Here is a l… Read More
Market snapshot.
The honeycomb fabrics market size and share is expected to reach approximately USD 1 billion in 2023, growing at a CAGR of around 9% during the forecast period. Furthermo… Read More
Share
Germany’s Boehringer Ingelheim said on Thursday it would conduct three late-stage studies for its obesity drug candidate after it showed up to 19% weight loss after 46 w… Read More
Agentix Corp. invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference on Wednesd… Read More
Research Nester released a report titled “Non-Alcoholic Steatohepatitis (NASH) Therapeutics & Diagnostics Market: Global Demand Analysis & Opportunity Outlook 2027”… Read More
Research Nester released a report titled “Non-Alcoholic Steatohepatitis (NASH) Therapeutics & Diagnostics Market: Global Demand Analysis & Opportunity Outlook 2027”… Read More
Reports and Insights recently issued a fresh report in their database titled, “Non-alcoholic Steatohepatitis (NASH) Biomarkers Market: Opportunity Analysis and Future Assessment 2023-2… Read More
Akero Therapeutics, Inc. (NASDAQ:AKRO) has recently made headlines due to the sale of 25,000 shares of its stock by CEO Andrew Cheng. The transaction took place on Monday, July 3rd, with eac… Read More
The global Non-alcoholic Steatohepatitis (NASH) market is expected to reach USD 180.09 Billion by 2028, according to a new report by Reports and Data. This can be mainly asso… Read More
The ‘Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share, Report and Forecast 2022-2027’ by Expert Market Research gives an extensive outlook of the global no… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Obesity pipeline constitutes 100+ key companies continuously working towards developing 130+ Obesity tr… Read More
PRESS RELEASE
Printed April 23, 2023
Digital Advertising Company Market Development and Business Income Analysis Report 2023: supplies all-inclusive replace on development segments, latest… Read More
U.S. shares edged up Wednesday in uneven buying and selling as merchants eyed the troublesome alternative going through the Federal Reserve of whether or not to prioritize combating infla… Read More
Integrins are cell adhesion and signaling proteins that play important roles in a wide range of biological functions. Currently, integrin-targeting drugs have been extensively developed in a… Read More
Gastroenterology and hepatology diseases have a high global prevalence and disease burden in the U.S. To meet the growing need of patients worldwide, the global gastrointestinal (GI) drugs m… Read More
Source: Streetwise Reports (12/28/22)
It’s valued the world over as a precious metal, and now it’s in demand for the green economy. Which element has asset manager Che… Read More